Skip to main content
Philogen logo

Philogen — Investor Relations & Filings

Ticker · PHIL ISIN · IT0005373789 LEI · 81560009EA1577917768 XMIL Manufacturing
Open in API
Filings indexed 377 across all filing types
Latest filing 2023-03-01 Transaction in Own Shar…
Country IT Italy
Listing XMIL PHIL

About Philogen

https://www.philogen.com

Philogen is a clinical-stage biotechnology company focused on the discovery and development of novel biopharmaceutical products for the treatment of cancer and other serious conditions associated with angiogenesis. Founded in 1996, the company's core strategy is based on innovating targeted therapies, such as antibody-cytokine fusions, which are designed to selectively deliver therapeutic agents to the site of disease. This approach aims to increase efficacy while reducing toxicity. Philogen operates as an integrated company with capabilities in research, GMP manufacturing, and clinical development of its proprietary product pipeline.

Recent filings

Filing Released Lang Actions
Allegato 3F - Febbraio 2023
Transaction in Own Shares Classification · 99% confidence The document is titled "SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI DELL'EMITTENTE" (MODEL DISCLOSURE FOR TRANSACTIONS IN THE ISSUER'S SECURITIES). It details transactions (Acquisition/Sale, Quantity, Price) involving the issuer's shares (PHILOGEN S.p.A.) during a specific reference period (02/2023). This structure is characteristic of mandatory regulatory filings reporting insider or related-party transactions in the company's own stock. This aligns directly with the definition for Director's Dealing (DIRS), which covers reports of personal share transactions by directors and executives, or more broadly, transactions in own shares (POS). Given the detailed, structured format reporting daily transactions by the issuer itself (or a related party identified in Section 1), it strongly suggests a regulatory filing concerning share transactions. Since the definition for 'Transaction in Own Shares' (POS) covers the company buying back or selling its own shares, and this document details transactions in the issuer's securities, POS is the most precise fit, although DIRS is also related to insider trading reports. However, the template structure is a standard form for reporting transactions in the issuer's securities, which often encompasses insider dealing or company repurchases. Since the reporting party is listed as PHILOGEN S.p.A. itself (Section 1), this points towards a report on the company's own share activity, making POS the best fit over DIRS (which usually focuses on directors' personal trades).
2023-03-01 Italian
2023 02 24 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 99% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of own shares purchased by Philogen S.p.A. during a specific period (February 20 to February 24, 2023), including daily transaction tables and total amounts. This activity directly corresponds to the definition of a company reporting transactions involving its own shares, which aligns with the 'Transaction in Own Shares' category (POS). It is not a general earnings release (ER), a full annual report (10-K), or a proxy statement (DEF 14A/PSI).
2023-02-27 Italian
2023 02 17 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 99% confidence The document is titled 'AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE' (Update on the Share Buyback Program) and details the number of own shares purchased by Philogen S.p.A. during a specific period (February 13, 2023, to February 17, 2023), including daily transaction breakdowns and total consideration. This activity directly relates to the company managing its own capital structure by repurchasing shares. This aligns perfectly with the definition for 'Transaction in Own Shares' (Code: POS). It is not a general financing update (CAP), nor is it a major shareholding notification (MRQ) which typically reports changes by external parties crossing thresholds.
2023-02-20 Italian
2023 02 10 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 99% confidence The document is titled "AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE" (Update on the Share Buyback Program) and details the number of own shares purchased by Philogen S.p.A. during a specific period (February 6, 2023, to February 10, 2023), including daily transaction breakdowns. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps precisely to the 'Transaction in Own Shares' category (POS). It is not a general regulatory filing (RNS) because it concerns a specific, defined corporate action, nor is it a proxy statement (DEF 14A) or an earnings release (ER).
2023-02-13 Italian
Allegato 3F - Gennaio
Director's Dealing Classification · 99% confidence The document is titled "SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI" / "MODEL DISCLOSURE FOR TRANSACTIONS IN THE ISSUER'S SECURITIES". It details transactions (purchases/acquisitions, indicated by 'A' in column 12) conducted by the issuer (PHILOGEN S.p.A.) in its own shares during January 2023. This directly corresponds to the definition of a report detailing the company buying back or selling its own shares, which is classified as 'Transaction in Own Shares'. The specific code for this is POS.
2023-02-06 Italian
2023 02 03 - CS settimanale acquisto azioni proprie ITA
Transaction in Own Shares Classification · 99% confidence The document is titled 'AGGIORNAMENTO SUL PROGRAMMA DI ACQUISTO DI AZIONI PROPRIE' (Update on the Share Buyback Program) and details the number of shares purchased by Philogen S.p.A. between January 30, 2023, and February 3, 2023. This explicitly describes a transaction where the company is buying back its own shares. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The document is a formal announcement/press release detailing these transactions, not a general regulatory filing (RNS) or a report of a different nature.
2023-02-06 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.